Pocket Guidelines on Valvular Heart Disease
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Pocket Guidelines on Valvular Heart Disease

ESC Pocket Guidelines

CV Surgery - Valves
Valvular Heart Disease
Non-coronary Cardiac Intervention

Publication Date: 2021

Chairperson: Alec Vahanian and Friedhelm Beyersdorf

Order Pocket Guidelines

 

Table of Content

  • Introduction
  • General comments
    • Concepts of Heart Team and Heart Valve Centre
    • Patient evaluation
    • Risk stratification
    • Patient related aspects
    • Local resources
    • Management of associated conditions
    • Endocarditis prophylaxis
    • Prophylaxis for rheumatic fever.
  • Aortic regurgitation
    • Evaluation
    • Indications for intervention
    • Medical therapy
    • Serial testing
    • Special patient populations
  • Aortic stenosis
    • Evaluation
    • Indications for intervention (SAVR or TAVI)
    • Medical therapy
    • 4 Serial testing
    • 5 Special patient populations
  • Mitral regurgitation
    • Primary mitral regurgitation
    • Secondary mitral regurgitationMitral stenosis
      • Rheumatic mitral stenosis
      • Degenerative mitral stenosis with mitral annular calcification
  • Tricuspid regurgitation
    • Evaluation
    • Indications for intervention
    • Medical therapy
  • Tricuspid stenosis
    • Evaluation
    • Indications for intervention
    • Medical therapy
  • Combined and multiple-valve diseases
  • Prosthetic valves
    • Choice of prosthetic valve
    • Baseline assessment and follow-up
    • Antithrombotic management
    • Management of prosthetic valve dysfunction and complications
  • Management during non-cardiac surgery
    • Preoperative evaluation
    • Specific valve lesions
    • Perioperative monitoring
  • Management during pregnancy
    • Management before pregnancy
    • Management during pregnancy
  • Supplementary data